Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yubin Ge

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Cell Cycle (Georgetown, Tex.)|December 30, 2017
ONC201 shows promise in AML treatmentHolly Edwards, Yubin Ge
Leukemia & Lymphoma|April 6, 2004
The prenatal origin of childhood acute lymphoblastic leukemiaJeffrey W Taub, Yubin Ge
Pediatric Blood & Cancer|September 25, 2004
Down syndrome, drug metabolism and chromosome 21Jeffrey W Taub, Yubin Ge
Journal of Chemical Information and Modeling|December 20, 2018
Development and Testing of Druglike Screening LibrariesJunmei Wang, Yubin Ge, Xiang-Qun Xie
Expert Review of Hematology|November 19, 2010
Unique clinical and biological features of leukemia in Down syndrome childrenAna C Xavier, Yubin Ge, Jeffrey Taub
Oncotarget|August 6, 2016
Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumorsSidra Ahsan, Yubin Ge, Michael A Tainsky
Pediatric Blood & Cancer|May 14, 2020
COVID-19 and childhood acute lymphoblastic leukemiaJeffrey W Taub, Yubin Ge, Ana C Xavier
The Journal of Molecular Diagnostics : JMD|August 28, 2009
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathologyAna C Xavier, Yubin Ge, Jeffrey W Taub
Expert Review of Hematology|September 19, 2014
Prognosis and management of acute myeloid leukemia in patients with Down syndromeJ Timothy Caldwell, Yubin Ge, Jeffrey W Taub
Cancer Management and Research|May 24, 2019
Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemiaTristan Knight, Holly Edwards, Jeffrey W Taub, et al.
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Cell Cycle (Georgetown, Tex.)|December 30, 2017
ONC201 shows promise in AML treatmentHolly Edwards, Yubin Ge
Leukemia & Lymphoma|April 6, 2004
The prenatal origin of childhood acute lymphoblastic leukemiaJeffrey W Taub, Yubin Ge
Pediatric Blood & Cancer|September 25, 2004
Down syndrome, drug metabolism and chromosome 21Jeffrey W Taub, Yubin Ge
Journal of Chemical Information and Modeling|December 20, 2018
Development and Testing of Druglike Screening LibrariesJunmei Wang, Yubin Ge, Xiang-Qun Xie
Expert Review of Hematology|November 19, 2010
Unique clinical and biological features of leukemia in Down syndrome childrenAna C Xavier, Yubin Ge, Jeffrey Taub
Oncotarget|August 6, 2016
Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumorsSidra Ahsan, Yubin Ge, Michael A Tainsky
Pediatric Blood & Cancer|May 14, 2020
COVID-19 and childhood acute lymphoblastic leukemiaJeffrey W Taub, Yubin Ge, Ana C Xavier
The Journal of Molecular Diagnostics : JMD|August 28, 2009
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathologyAna C Xavier, Yubin Ge, Jeffrey W Taub
Expert Review of Hematology|September 19, 2014
Prognosis and management of acute myeloid leukemia in patients with Down syndromeJ Timothy Caldwell, Yubin Ge, Jeffrey W Taub
Cancer Management and Research|May 24, 2019
Evaluating venetoclax and its potential in treatment-naïve acute myeloid leukemiaTristan Knight, Holly Edwards, Jeffrey W Taub, et al.
Pageof 14